Medscape: Thrombectomy benefits stroke with large core volumes
UC's Broderick comments on international trial
Results of a new international trial showed performing endovascular thrombectomy in stroke patients with a large ischemic core is beneficial.
Endovascular thrombectomy is a minimally invasive procedure for acute ischemic stroke patients that uses a catheter to remove a blood clot from a blood vessel in the brain, which restores blood flow. Patients with strokes with a large ischemic core were previously not considered candidates for thrombectomies because of concerns of an increased risk of hemorrhage, disability and death.
Joseph Broderick, MD, professor in UC’s Department of Neurology and Rehabilitation Medicine in the College of Medicine, director of the UC Gardner Neuroscience Institute and a UC Health physician, told Medscape the study results were "robust and important."
The results of the trial "will change practice and extend endovascular therapy to more patients with severe strokes," Broderick continued. However, he noted imaging will still be necessary to exclude a certain subset of patients with large ischemic core who were not included in the trials.
"These are patients who have very large areas of clear hypodensity on the baseline image (brain already dying or dead)," Broderick said. "These patients do not benefit from reperfusion with lytic drugs or endovascular therapy."
Read the Medscape article. (Note: Account creation or log-in may be required to view full article.)
Featured photo at top of brain scans. Photo/Joseph Fuqua II/UC Marketing + Brand.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.